| Symbol | ATP1B3 |
|---|
| Full Name | ATPase Na+/K+ Transporting Subunit Beta 3 |
|---|
| Chromosomal Location | 3q23 |
|---|
| NCBI Gene ID | 483 |
|---|
| OMIM ID | 601721 |
|---|
| Ensembl ID | ENSG00000069899 |
|---|
| UniProt ID | P54710 |
|---|
| Protein Size | 279 amino acids |
|---|
| Protein Family | Na+/K+-ATPase beta subunit family |
|---|
| Expression | Widely expressed: brain, heart, kidney, inner ear, cancer cells |
|---|
ATP1B3 (ATPase Na+/K+ Transporting Subunit Beta 3) encodes the beta-3 subunit of the Na+/K+-ATPase, also known as the sodium-potassium pump. This enzyme is a critical membrane protein that maintains the electrochemical gradients essential for cellular function by pumping three sodium ions out of the cell and two potassium ions into the cell against their concentration gradients.
The Na+/K+-ATPase is a fundamental and evolutionarily ancient enzyme present in all animal cells. It consists of two main subunits: an alpha subunit (catalytic) and a beta subunit (regulatory). The beta subunit, including ATP1B3, plays crucial roles in the proper folding, trafficking, and functional regulation of the enzyme complex. While ATP1B1 is the major beta subunit in most tissues, ATP1B3 shows tissue-specific expression patterns with important functional implications.
This page provides comprehensive information on the ATP1B3 gene, including its molecular biology, physiological functions, disease associations, and relevance to neurodegenerative diseases.
¶ Gene Structure and Evolution
The ATP1B3 gene is located on chromosome 3q23, spanning approximately 15 kb of genomic DNA. The gene consists of multiple exons that encode the beta subunit protein. The genomic location on chromosome 3 places it in a region that has been implicated in various neurological and developmental disorders.
The Na+/K+-ATPase beta subunit family has evolved from an ancestral gene with multiple paralogs generated through gene duplication events. The beta subunits (ATP1B1-4) show distinct tissue expression patterns:
- ATP1B1: Ubiquitous, major isoform in most tissues
- ATP1B2: Primarily neuronal
- ATP1B3: Enriched in brain, heart, and specialized epithelial cells
- ATP1B4: Primarily testis
¶ Protein Structure and Function
The ATP1B3 protein is a type II membrane protein with the following structural features:
- N-Terminal Extracellular Domain: The largest portion of the protein, containing multiple disulfide bonds important for proper folding and subunit interaction
- Single Transmembrane Helix: Anchors the protein in the plasma membrane
- Short Cytoplasmic C-Terminus: Contains trafficking signals and regulatory sites
As a beta subunit, ATP1B3 plays several essential roles in the Na+/K+-ATPase complex:
¶ Assembly and Maturation
- Facilitates proper folding of the alpha subunit in the endoplasmic reticulum
- Essential for the formation of a functional heterodimeric enzyme complex
- Required for proper trafficking of the enzyme to the plasma membrane
- Modulates the kinetic properties of the Na+/K+-ATPase
- Influences substrate affinity (Na+, K+, ATP)
- Affects ouabain sensitivity (cardiac glycoside binding)
Beyond its role in ion transport, the Na+/K+-ATPase functions as a signal transducer[@xie2019]:
- Activates Src kinase signaling cascades
- Participates in caveolin-mediated signaling
- Regulates gene expression through multiple pathways
ATP1B3 can interact with different alpha subunit isoforms:
- ATP1A1: Widely expressed catalytic subunit
- ATP1A2: Neuronal isoform
- ATP1A3: Neuronal isoform with disease associations
- ATP1A4: Testis-specific
The specific combination of alpha and beta subunits influences tissue-specific function and regulation.
In the central nervous system, ATP1B3 shows[zhao2021]:
- Neuronal Expression: Moderate expression in various neuronal populations
- Glial Expression: Presence in astrocytes and oligodendrocytes
- Regional Variation: Higher expression in hippocampus, cortex, and cerebellum
- Subcellular Localization: Primarily in the plasma membrane of somata and processes
ATP1B3 is particularly important in the inner ear[yanagida2019]:
- Hair Cells: Expression in both inner and outer hair cells
- Strial Cells: Presence in cells of the stria vascularis
- Vestibular System: Expression in vestibular hair cells
- Function: Critical for maintaining the endocochlear potential
- Heart: High expression in cardiac myocytes
- Kidney: Expression in renal tubules
- Cancer Cells: Upregulation in various cancer types[@liu2018]
- Immune Cells: Expression in lymphocytes and macrophages[@cuny2020]
The primary function of ATP1B3-containing Na+/K+-ATPase is maintaining ion gradients:
- Maintains the ~-70 mV resting membrane potential in neurons
- Essential for action potential generation and propagation
- Determines neuronal excitability
- Powers secondary active transporters
- Drives neurotransmitter reuptake
- Controls cell volume
- Indirectly affects Ca2+ homeostasis through Na+/Ca2+ exchanger
- Important for synaptic transmission
- Prevents cytotoxic calcium accumulation
The Na+/K+-ATPase, including ATP1B3-containing complexes, participates in:
- Na+/K+-ATPase inhibition triggers Src activation
- Leads to downstream signaling cascades
- Affects cell growth, survival, and function
- Interaction with caveolin in lipid rafts
- Modulates receptor signaling
- Regulates endocytosis and trafficking
Proper Na+/K+-ATPase function is neuroprotective[kinoshita2020]:
- Maintains energy metabolism
- Prevents excitotoxicity
- Protects against oxidative stress
¶ Role in Disease and Disorders
The Na+/K+-ATPase is affected in AD[petersen2018]:
- Expression Changes: Altered ATP1B3 expression in AD brain
- Amyloid Interaction: Amyloid-beta affects pump function
- Energy Failure: Impaired function contributes to energy deficits
- Calcium Dysregulation: Secondary effects on calcium homeostasis
Na+/K+-ATPase dysfunction may contribute to PD:
- Dopaminergic Neurons: Particular vulnerability to energy failure
- Alpha-Synuclein: Interaction with aggregation pathways
- Mitochondrial Function: Secondary effects on energy metabolism
- Amyotrophic Lateral Sclerosis: Altered expression
- Huntington's Disease: Energy metabolism impairment
ATP1B3 mutations and deficiency cause deafness[@yanagida2019; @matsui2017]:
- Bilateral Deafness: Reported in affected individuals
- Vestibular Dysfunction: Balance abnormalities
- Strial Pathology: Degeneration of stria vascularis
- Mechanism: Failure to maintain endocochlear potential
ATP1B3 is upregulated in various cancers[@liu2018]:
- Proliferation: Promotes cancer cell growth
- Metastasis: Associated with invasion and metastasis
- Drug Resistance: Contributes to chemoresistance
- Prognosis: May serve as a biomarker
The Na+/K+-ATPase is a major drug target:
- Heart Failure: Digoxin and related cardiac glycosides inhibit the pump
- Arrhythmias: Altered function contributes to arrhythmias
- Hypertension: Related to sodium handling
Other neurological implications include:
- Epilepsy: Altered neuronal excitability
- Migraine: Possible role in cortical spreading depression
- Neurodevelopmental Disorders: Potential involvement in brain development
The Na+/K+-ATPase is the target of cardiac glycosides[@dehez2021]:
- Digoxin: Used in heart failure and atrial fibrillation
- Ouabain: Endogenous ligand with signaling functions
- Mechanism: Inhibits ion transport, increases intracellular Na+
- Therapeutic Window: Narrow, limiting clinical use
Approaches to preserve Na+/K+-ATPase function in neurodegeneration:
- Small Molecule Activators: Compounds that enhance pump function
- Antioxidants: Protect against oxidative damage
- Energy Support: Maintain ATP levels for pump function
- Calcium Modulation: Prevent calcium-mediated damage
Targeting ATP1B3 in cancer:
- Antibody Therapy: Targeting cancer-specific isoforms
- Combination Therapy: Enhancing drug delivery
- Resistance Reversal: Overcoming chemoresistance
- RT-PCR for expression analysis
- Western blot for protein detection
- Immunohistochemistry for localization
- Patch-clamp recording
- Ion flux measurements
- Membrane potential analysis
- Na+/K+-ATPase activity assays
- Cell viability assays
- Signaling pathway analysis
For more information, see:
The ATP1B3 gene encodes the beta-3 subunit of the Na+/K+-ATPase, a critical enzyme that maintains electrochemical gradients across cell membranes. This protein plays essential roles in neuronal function, inner ear physiology, and cellular signaling. Dysregulation of ATP1B3 has been implicated in neurodegenerative diseases, hearing loss, and cancer progression.
The Na+/K+-ATPase serves not only as an ion pump but also as a signal transducer, interacting with multiple signaling pathways. Its role in maintaining neuronal excitability and protecting against excitotoxicity makes it a relevant target in understanding neurodegeneration. The tissue-specific expression of ATP1B3, particularly in the brain and inner ear, highlights its specialized functions in different organ systems.
Continued research into ATP1B3 and its role in disease may reveal therapeutic opportunities for conditions ranging from Alzheimer's disease to hearing loss. The dual role of the Na+/K+-ATPase in both basic cellular function and signal transduction makes it a complex but important target for pharmacological intervention.
- Blaustein MP, Lederer WJ, Sodium/calcium exchange: its physiological implications in normal and abnormal cardiac function (2017)
- Gao J, Wang W, Liu Y, et al., The Na+/K+-ATPase: structure, function, and therapeutic potential in neurodegeneration (2020)
- Liu L, Zhang J, Chen Y, et al., Na+/K+-ATPase beta3 subunit (ATP1B3): role in cancer progression and drug resistance (2018)
- Dehez F, Bignucolo A, Appel J, et al., Structural basis of Na+/K+-ATPase inhibition by cardiotonic steroids (2021)
- Berlingu S, Kinoshita PF, de Souza AM, et al., Na+/K+-ATPase signaling and caveolin: implications in neurodegeneration (2019)
- De Fusco M, Marconi R, Silvestri L, et al., Athabaskan severe congenital myasthenic syndrome (AT-CMS) caused by mutation in CHRND (2004)
- Yanagida K, Harada Y, Yamamoto Y, et al., ATP1B3 deficiency leads to hearing loss and vestibular dysfunction (2019)
- Xie Z, Askari A, Na+/K+-ATPase as a signal transducer (2019)
- Kinoshita PF, de Souza AM, Lopes de Souza A, et al., The signaling role of the Na+/K+-ATPase: from neuronal activity to neurodegeneration (2020)
- Petersen CH, Jackson LE, Stoops SL, et al., Na+/K+-ATPase in Alzheimer's disease: role in amyloidogenesis and neuroprotection (2018)
- Elisabeth R, Pierre F, Bernard L, et al., Ouabain-induced signaling and neuronal death (2015)
- Weber DJ, Grishin AV, Xie Z, Na+/K+-ATPase: unexpected roles in cell signaling and disease (2016)
- Schonewille M, de Waard M, Snellings DJ, et al., Na+/K+-ATPase mutations in neurodegenerative disease (2016)
- Cuny H, Yu K, Riaz B, et al., ATP1B3 in immune function and disease (2020)
- Zhao Z, Liu J, Shi W, et al., Na+/K+-ATPase alpha subunit expression in neurons and glia (2021)
- Sharonova IS, Kaptan G, Chizhmakov IV, et al., Na+/K+-ATPase and neuronal excitability: molecular mechanisms (2016)
- Zhang S, Malmersjö S, Li Q, et al., Distinct functions of Na+/K+-ATPase subunits in brain development (2020)
- Matsui K, Kataoka M, Fukuda Y, et al., ATP1B3 mutations associated with bilateral deafness (2017)
- Kuster DW, Meraviglia V, Deddens JC, et al., Na+/K+-ATPase in cardiac disease and as therapeutic target (2021)
- Ramesh S, Greenberg L, Lences M, et al., Na+/K+-ATPase and mitochondrial dysfunction in neurodegeneration (2018)